Effects of cyborg-type robot suit HAL on exercise therapy in patients with chronic heart failure

Effects of cyborg-type robot suit HAL on exercise therapy in patients with chronic heart failure - Effects of HAL on exercise therapy in CHF patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030761

Enrollment

Registered

2018-02-01

Start date

2018-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients with chronic heart failure

Interventions

Wearing of Robot suit HAL Time: 5-30 minutes /day Frequency: 3-5 days /week Duration: approximately 2 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: A patient with chronic heart failure who meets the criteria of exercise therapy (cardiac rehabilitation) by health insurance

Exclusion criteria

Exclusion criteria: A patient who correspond to contraindication to exercise therapy

Design outcomes

Primary

Measure	Time frame
heart rate, blood pressure, and symptom during exercise therapy	—

Secondary

Measure	Time frame
1) days from the start of exercise therapy until the walking by oneself 2) days from the start of exercise therapy until the discharge from hospital 3) adverse events 4) prognosis during 1 year from discharge	—

Countries

Japan

Contacts

Public ContactAkira Koike

Faculty of Medicine, University of Tsukuba Department of Cardiology

koike@md.tsukuba.ac.jp029-853-3210

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026